Cisplatin ototoxicity and protection: clinical and experimental studies.

Cisplatin ototoxicity and protection: clinical and experimental studies.
复制标题

DOI:
10.1620/tjem.219.177
复制
发表时间:
2009-11
期刊:
The Tohoku journal of experimental medicine
影响因子:
--
通讯作者:
Ramkumar V
Ramkumar V
中科院分区:
其他
文献类型:
--
作者:
Rybak LP;Mukherjea D;Jajoo S;Ramkumar V

文献摘要

参考文献

被引文献

相似文献

顺铂是一种广泛用于治疗多种恶性肿瘤的化疗剂。严重的剂量限制性副作用,如耳毒性,肾毒性和神经毒性发生与使用这种药物。本文就顺铂耳毒性的临床和实验研究进展作一综述。它还讨论了在病人和实验动物中使用的保护剂的效用。未来限制顺铂耳毒性的策略需要避免干扰顺铂的治疗效果,以提高接受这种重要抗肿瘤药物的患者的生活质量。
Cisplatin is a chemotherapeutic agent that is widely used to treat a variety of malignant tumors. Serious dose-limiting side effects like ototoxicity, nephrotoxicity and neurotoxicity occur with the use of this agent. This review summarizes recent important clinical and experimental investigations of cisplatin ototoxicity. It also discusses the utility of protective agents employed in patients and in experimental animals. The future strategies for limiting cisplatin ototoxicity will need to avoid interference with the therapeutic effect of cisplatin in order to enhance the quality of life of patients receiving this important anti-tumor agent.
DOI: 10.1016/s0378-5955(96)00152-9
发表时间: 1996-12-01
期刊: HEARING RESEARCH
影响因子: 2.8
作者:
Campbell, KCM;Rybak, LP;Hughes, L
通讯作者: Hughes, L
DOI: 10.1016/j.heares.2004.02.007
发表时间: 2004-07-01
期刊: HEARING RESEARCH
影响因子: 2.8
作者:
Dickey, DT;Muldoon, LL;Neuwelt, EA
通讯作者: Neuwelt, EA
DOI: 10.1016/s0006-2952(00)00441-x
发表时间: 2000-11-01
影响因子: 5.8
作者:
Ferry, KV;Hamilton, TC;Johnson, SW
通讯作者: Johnson, SW
DOI: 10.1074/jbc.m407448200
发表时间: 2004-10-29
影响因子: 4.8
作者:
DeVries, TA;Kalkofen, RL;Reyland, ME
通讯作者: Reyland, ME
DOI: 10.1080/00016480701881811
发表时间: 2008-01-01
影响因子: 1.4
作者:
Chung, Won-Ho;Boo, Sung Hyun;Hong, Sung Hwa
通讯作者: Hong, Sung Hwa